At the first 8 h, TP@HSA NPs group could better target arthritis joints, but TP@HSA NPs-Gel group showed advantage at 24 h and 48 h, which means that gel can control the release of TP@HSA NPs and help them to slowly target arthritis joints. Here, ALB is linked to arthritic joint disease.